Literature DB >> 15591529

Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol.

N Krikis, K Tziomalos, V Perifanis, S Vakalopoulou, A Karagiannis, V Garipidou, F Harsoulis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15591529      PMCID： PMC1774363          DOI： 10.1136/gut.2004.049031

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract.

Authors:  P Orsi; C Guatti-Zuliani; L Okolicsanyi
Journal:  Dig Liver Dis       Date:  2001-05       Impact factor: 4.088

2.  The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract.

Authors:  G Nardone; A Rocco; T Balzano; G Budillon
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

3.  Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia.

Authors:  M R Andersen; J Aaseby
Journal:  Scand J Gastroenterol       Date:  1996-10       Impact factor: 2.423

Review 4.  How I treat patients with von Willebrand disease.

Authors:  P M Mannucci
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

Review 5.  Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly.

Authors:  J C Gillis; S Noble; K L Goa
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

6.  Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease.

Authors:  M Bowers; O McNulty; E Mayne
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

Review 7.  Long-acting formulations of somatostatin analogues.

Authors:  L B Anthony
Journal:  Ital J Gastroenterol Hepatol       Date:  1999-10

8.  Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine.

Authors:  F P Rossini; A Arrigoni; M Pennazio
Journal:  Am J Gastroenterol       Date:  1993-09       Impact factor: 10.864
  8 in total
  3 in total

1.  Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation.

Authors:  Carl Friedrich Classen; Dieter Haffner; Christina Hauenstein; Ricarda Wolf; Ulrike Kyank
Journal:  BMJ Case Rep       Date:  2011-08-17

Review 2.  New insights to occult gastrointestinal bleeding: From pathophysiology to therapeutics.

Authors:  Antonio Damián Sánchez-Capilla; Paloma De La Torre-Rubio; Eduardo Redondo-Cerezo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 3.  Current and Emerging Options for the Management of Inherited von Willebrand Disease.

Authors:  Jessica M Heijdra; Marjon H Cnossen; Frank W G Leebeek
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.